title: Treatment of lactose intolerance with exogenous beta-D-galactosidase in pellet form.
abstract: The effectiveness of a new beta-D-galactosidase pellet formulation in the treatment of lactose intolerance was studied. The encapsuled beta-D-galactosidase (lactase) pellets were first tested in vitro for their enzymatic activity within an environment simulating gastric conditions and subsequently within an environment simulating duodenal conditions. Effectiveness was measured by the % of glucose formed by hydrolysis of lactose. The pellets were found to retain their enzymatic activity in gastric pH conditions (mean 69 +/- 1 mg/dl glucose) and were found to hydrolyse lactose in human duodenal fluid (106.35 +/- 1 mg/dl). Finally the effectiveness of the new lactase formulation on glucose absorption was studied in 8 lactose intolerant subjects in a randomized, double blind, crossover trial. After fasting, the subjects were given one capsule containing 100 u/ml beta-galactosidase (i.e. 10 pellets of 10 u/ml each) or one capsule containing placebo pellets, followed by 100 g lactose dissolved in water. The washout period between lactose challenges was one week. Plasma glucose concentrations were measured before and at intervals after the challenges and the subjects completed symptom questionnaires every eight hours for 24 hours. Results showed a statistically significant increase in plasma glucose levels 30, 60, 90 and 120 min after lactose ingestion (repeated measures analysis of variance, p<0.01). Subjective ratings of the severity of abdominal cramping, belching, flatulence, vomiting and diarrhoea were significantly decreased following ingestion of the lactase pellets and lactose (no incidence of diarrhoea) compared with after ingestion of placebo and lactose. The results of the study were considered to be very promising as the beta-D-galactosidase formulation (which was produced at very low cost and with great ease) resisted inactivation in the stomach, effectively transformed lactose to glucose in vivo and reduced symptoms of lactose intolerance.
authors.affiliation: Department of Dermatology, University of Athens, A. Sygros Hospital, Greece.
authors.forename: K
authors.initials: K
authors.lastname: Xenos
authors.forename: S
authors.initials: S
authors.lastname: Kyroudis
authors.forename: A
authors.initials: A
authors.lastname: Anagnostidis
authors.forename: P
authors.initials: P
authors.lastname: Papastathopoulos
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002214:Capsules; D006801:Humans; D007787:Lactose Intolerance / Q000188:drug therapy*; D016896:Treatment Outcome; D001616:beta-Galactosidase / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D002214:Capsules; D001616:beta-Galactosidase